Novus International, Inc.
8 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Feb 2031
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 25, 2027The maintenance fee for Process for the manufacture of acrolein (US 9,115,067) comes due Feb 25, 2027. Unpaid by Aug 25, 2027, it lapses early.
- 1 fee due Apr 29, 2027The maintenance fee for Heteroatom containing cyclic dimers (US 10,457,660) comes due Apr 29, 2027. Unpaid by Oct 29, 2027, it lapses early.
- 2 fees due Sep 3 to 30, 2027 · next Sep 3
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,968,791 | Dietary supplements for promotion of growth, repair, and maintenance of bone and joints In force · USPTO record | In force | USPTO record | |
| US 8,865,920 | N-acylation of amines In force · USPTO record | In force | USPTO record | |
| US 8,476,427 | Preparation of methionine or selenomethionine from homoserine via a carbamate intermediate In force · USPTO record | In force | USPTO record | |
| US 9,023,345 | Methods for Improving Gut Health In force · High confidence | In force | High confidence | |
| US 8,742,170 | Preparation of methionine or selenomethionine from homoserine via a 4-substituted 2-aminobutanoic acid intermediate In force · USPTO record | In force | USPTO record | |
| US 9,011,832 | Heteroatom containing cyclic dimers In force · USPTO record | In force | USPTO record | |
| US 10,457,660 | Heteroatom containing cyclic dimers In force · USPTO record | In force | USPTO record | |
| US 9,115,067 | Process for the manufacture of acrolein In force · USPTO record | In force | USPTO record | |
| US 10,604,479 | Continuous process for the one-pot synthesis of metal salts and metal complexes In force · USPTO record | In force | USPTO record | |
| US 9,801,845 | Antimicrobial compositions and uses thereof In force · USPTO record | In force | USPTO record |
Also on record, not counted in the 18: 8 patents in force now held by others · 32 lapsed for an unpaid fee · 50 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending · 46 no status recorded